Article metrics

Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study

 

Online download statistics by month:

Online download statistics by month: October 2020 to July 2022

AbstractFullPdf
Oct 202016916893
Nov 2020555331
Dec 2020353513
Jan 2021333210
Feb 202126259
Mar 2021242410
Apr 2021322815
May 2021191811
Jun 2021353416
Jul 2021363421
Aug 2021393939
Sep 2021222116
Oct 2021242431
Nov 2021212016
Dec 2021212216
Jan 2022424716
Feb 2022353217
Mar 2022323314
Apr 2022505112
May 2022313115
Jun 202215156
Jul 202237345
Total833820432